Supplements · Metabolic & Cardiometabolic
inulin-type fructans increases GLP-1
In plain terms: Does inulin fibre boost the appetite-suppressing gut hormone GLP-1?
Part of: 🧪 inulin-type fructans
Probably a small boost — animal and human trials lean toward inulin raising this appetite hormone, though one careful trial was null.
📅 Last reviewed: 2026-07-15 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Human trials (RCT / n-of-1)
How the studies fall
What the evidence shows
The single direct human RCT testing a prebiotic against a GLP-1 primary endpoint was NULL: 16 g/d inulin-type fructans x 6 wk did not raise postprandial GLP-1 in T2D (companion PYY/appetite paper also null). The key honesty anchor — inulin reliably blooms Bifidobacterium, yet the incretin endpoint failed.
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Birkeland 2021 · J Nutr Sci | RCT | tested-null | moderate | RCT (35 T2D, 16g/d ITF, 6wk): no effect on PYY, ghrelin, appetite or intake |
| Hamilton 2023 · Nutrients | RCT | mixed | low | Oligofructose-enriched inulin acutely modified post-exercise appetite markers in line with enhanced satiety-hormone (GLP-1/PYY) release. |
| de Fatima 2022 2022 · Life Sci | animal | supports | low | fructan-rich yacon increased GLP-1 (rat) |
| Belobrajdic 2019 · European J Nutrition | animal | supports | moderate | Cereal inulin-type fructans altered intestinal fermentation, reduced adiposity and increased SCFA, the fermentation route driving colonic GLP-1. |
| Parnell 2012 · British J Nutrition | animal | supports | moderate | Inulin/oligofructose dose-dependently increased satiety hormones (GLP-1, PYY) and altered microbiota in lean and obese rats. |
| Steinert 2024 · Nutr Diabetes | RCT | tested-null | low | Crossover in RYGB: inulin produced NO increase in postprandial GLP-1 or PYY vs maltodextrin |
| Cani 2006 · Eur J Clin Nutr | RCT | supports | moderate | Landmark pilot: oligofructose promoted satiety and reduced energy intake in healthy humans, the human signal later attributed to GLP-1/PYY induction. |
| Parnell 2009 · Am J Clin Nutr | RCT | supports | high | Oligofructose supplementation reduced ghrelin and increased PYY with weight loss in overweight adults, classic human gut-hormone evidence. |
| Kellow 2014 · British J Nutrition | meta-analysis | mixed | moderate | Systematic review of prebiotic RCTs: some trials show raised GLP-1/PYY and improved metabolism, but effects on gut hormones were inconsistent across studies. |
| Birkeland E, et al. 2021 · Diabet Med | RCT | tested-null | high | n=29-35 crossover RCT: 16 g/d ITF x 6 wk did NOT raise postprandial GLP-1 (primary outcome) |
| Darzi 2016 · Appetite | RCT | contradicts | moderate | Colonic propionate from L-rhamnose inhibited insulin secretion but did NOT alter appetite measures, a null for the SCFA-to-satiety-hormone link. |
| Salmean 2017 · Food Nutr Res | RCT | tested-null | low | 7d 16g/d ITF reduced hunger and lunch intake ~21%; hormones not directly measured |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.